Cargando…
Introduction of Universal Newborn Screening for Sickle Cell Disease in Germany—A Brief Narrative Review
Autores principales: | Lobitz, Stephan, Kunz, Joachim B., Cario, Holger, Hakimeh, Dani, Jarisch, Andrea, Kulozik, Andreas E., Oevermann, Lena, Grosse, Regine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7931038/ https://www.ncbi.nlm.nih.gov/pubmed/33525323 http://dx.doi.org/10.3390/ijns7010007 |
Ejemplares similares
-
Benefits of a Disease Management Program for Sickle Cell Disease in Germany 2011–2019: The Increased Use of Hydroxyurea Correlates with a Reduced Frequency of Acute Chest Syndrome
por: Kunz, Joachim B., et al.
Publicado: (2021) -
Genetic modifiers of fetal hemoglobin affect the course of sickle cell disease in patients treated with hydroxyurea
por: Allard, Pierre, et al.
Publicado: (2021) -
5613004 NEWBORN SCREENING FOR SICKLE CELL DISEASE IN GERMANY - THE FIRST YEAR
por: Lobitz, S., et al.
Publicado: (2023) -
P1480: SPLENIC SEQUESTRATION IS MORE COMMON IN SCD-S/Β0-THAL THAN IN SCD-S/S PATIENTS: RESULTS FROM THE GERMAN SCD REGISTRY
por: Allard, P., et al.
Publicado: (2022) -
Transition in Sickle Cell Disease (SCD): A German Consensus Recommendation
por: Alashkar, Ferras, et al.
Publicado: (2022)